 SHANGHAI, Sept. 7, 2021 PRNewswire -- 111, Inc. 111 or the Company NASDAQ: YI, a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced that its board of directors the Board has authorized a share repurchase program under which the Company may repurchase up to 10 million of its Class A ordinary shares in the form of American depositary shares ADSs in the next twelve months collectively, the Share Repurchase Program. 